Chronic HCV infection and inflammation: Clinical impact on hepatic and extra-hepatic manifestations. - Wikidata - wikimedia - TriplyDB

Chronic HCV infection and inflammation: Clinical impact on hepatic and extra-hepatic manifestations.

Chronic HCV infection and inflammation: Clinical impact on hepatic and extra-hepatic manifestations.

http://www.wikidata.org/entity/Q38157936

about

HCV-Induced Oxidative Stress: Battlefield-Winning Strategy Hepatitis C virus and neurological damage Hepatocellular carcinoma: From clinical practice to evidence-based treatment protocols Assessing cardiovascular risk in hepatitis C: An unmet need Chronic hepatitis C virus infection and neurological and psychiatric disorders: an overview HCV RNA Activates APCs via TLR7/TLR8 While Virus Selectively Stimulates Macrophages Without Inducing Antiviral Responses Treatment with pirfenidone for two years decreases fibrosis, cytokine levels and enhances CB2 gene expression in patients with chronic hepatitis C.Prevalence and risk factors for patient-reported joint pain among patients with HIV/hepatitis C coinfection, hepatitis C monoinfection, and HIV monoinfection.HCV NS5A Up-Regulates COX-2 Expression via IL-8-Mediated Activation of the ERK/JNK MAPK Pathway.Sulforaphane Suppresses Hepatitis C Virus Replication by Up-Regulating Heme Oxygenase-1 Expression through PI3K/Nrf2 Pathway.Fibromyalgia symptoms and cirrhosis.Inhibitory effect of miR-125b on hepatitis C virus core protein-induced TLR2/MyD88 signaling in THP-1 cells Hepatocellular carcinoma: epidemiology and risk factors Alterations in the iron homeostasis network: A driving force for macrophage-mediated hepatitis C virus persistency.The effect of standard therapy on mean platelet volume in patients with chronic hepatitis C Grape Seed Extract Attenuates Hepatitis C Virus Replication and Virus-Induced Inflammation.Association of Toll-Like Receptor 3 Single-Nucleotide Polymorphisms and Hepatitis C Virus Infection.Hepatitis C virus and cardiovascular: A review.Chronic hepatitis C virus infection and atherosclerosis: clinical impact and mechanisms Atherosclerosis as a possible extrahepatic manifestation of chronic hepatitis C virus infection.Extrahepatic manifestations in chronic hepatitis C virus carriers.Hepatitis C virus coinfection as a risk factor for osteoporosis and fracture.Suppression of Host Innate Immune Response by Hepatitis C Virus via Induction of Autophagic Degradation of TRAF6.Hepatitis C Virus-Induced Autophagy and Host Innate Immune Response.Impaired Platelet Aggregation and Rebalanced Hemostasis in Patients with Chronic Hepatitis C Virus Infection.Prevalence of Hepatitis C Virus Seropositivity and Its Impact on Coronary Artery Disease among Egyptian Patients Referred for Coronary Angiography.Visceral Adiposity Index and the Degree of Hepatic Fibrosis and Inflammation in Egyptian Patients with Chronic Hepatitis C.Mcl-1 Is a Novel Target of miR-26b That Is Associated with the Apoptosis Induced by TRAIL in HCC Cells.Impact of diabetes mellitus and chronic liver disease on the incidence of dementia and all-cause mortality among patients with dementia.Prevalence and economic burden of extrahepatic manifestations of hepatitis C virus are underestimated but can be improved with therapy.Epidemiology of Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) Related Hepatocellular Carcinoma.Three variants in the nicotinamide adenine dinucleotide phosphate oxidase complex are associated with HCV-related liver damage.Neurological manifestations in chronic hepatitis C patients receiving care in a reference hospital in sub-Saharan Africa: A cross-sectional study.Comorbidities and co-medications in populations with and without chronic hepatitis C virus infection in Japan between 2015 and 2016.Oncogenic Signaling Induced by HCV Infection Hepatitis C Virus Clearance by Direct-acting Antiviral Results in Rapid Resolution of Hepatocytic Injury as Indicated by Both Alanine Aminotransferase and Aspartate Aminotransferase Normalization Chronic hepatitis C, atherosclerosis and cardiovascular disease: What impact of direct-acting antiviral treatments?

P2860

Q26746946-C821B877-CE53-4709-BF53-9E62635CC92F Q26748575-D0EF0637-90BE-46F2-8B43-71E7AA410620 Q26783881-7E13AF3C-4341-4338-AE01-4198A1A6164A Q26784258-A0290522-2C34-47BD-BB79-4D93629712C2 Q28082212-C995BCA0-F2C8-404C-9AA1-D25BBE3C5A34 Q28276935-30EA6BD5-123B-44D3-9508-9133B0602A44 Q34537906-2EAB8B85-4C4D-4D68-B828-194862D30EA9 Q35503257-54608DA9-EB59-436B-87C1-69F27B3ABBEC Q35731525-2252D4CF-8AAA-45D3-A50D-9769519926BD Q35972850-9DD102BD-87B5-48A6-9FA9-1635F59166F0 Q36396701-E4BE4E89-AAFD-4CFB-AE7A-15374BC555F9 Q36859975-833C32D5-8FFA-4B9A-A757-FCC17A76EF62 Q37031724-1706E722-DEEA-40B3-87A9-E73712863E9E Q37189857-52F1D846-B4F9-4934-9C97-097C473FFBF7 Q37306570-594B0C61-81AB-4EB3-9A5B-CEA1D2AE7711 Q37521412-C66FDA2B-26FA-4E6C-A953-EC1C43668A37 Q37588732-4551AF97-775D-44FB-B475-FA07C70E8232 Q37610905-300EBA55-54D7-4A4F-9F61-CB01B34145B7 Q37682486-E9437176-73CB-422D-86C5-22C1F709D4D9 Q38276377-5498CA64-3DA9-43E2-ADD4-B5F60CAD17C3 Q38388423-3A7708DE-AFC3-4EF0-9215-045F3710D8D6 Q38738823-C244F2F0-BDFD-4E3D-ABF9-2215E03BDCD0 Q38743328-4E1154DE-7618-4FE7-BC0F-561C2C9DC15F Q40084069-C8605A0E-1592-45AA-BDA0-BF7C883435CE Q40211125-50279DE8-C0F2-4BBD-8D9C-C69D2DAAE96B Q40459359-515690EB-D6AE-41CD-9130-8714479CE73D Q41926316-3C205CBA-3925-4AA6-8231-5AD8AB5CAD48 Q42180490-BC845DCA-16D3-4B80-8F4D-CE42BC7D2256 Q47097794-A5F65209-CC50-462B-B50F-72DD669C1D74 Q51366504-73621E15-D338-49FD-AA31-CF1038164FF6 Q52355121-70E456E6-D41C-45A6-8B2C-CD7E25407007 Q52384628-E0AC17FA-0FC6-4B43-82CC-28E723EC35A5 Q54260700-3E4CA697-C111-47FC-BF34-2DBAE8205F10 Q55093102-C0325D33-B664-40F0-98E4-6EFCB070515F Q57050806-52288F53-ADB6-418D-A0DE-6E291F084D48 Q57066931-50AC282A-822C-48AE-B774-1F97017458B9 Q58699647-365AFD7B-D481-49E3-930A-27A14EF6C0A4

P2860

Chronic HCV infection and inflammation: Clinical impact on hepatic and extra-hepatic manifestations.

http://www.wikidata.org/entity/Q38157936

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Chronic HCV infection and infl ...... extra-hepatic manifestations.

@en

type

label

Chronic HCV infection and infl ...... extra-hepatic manifestations.

@en

prefLabel

Chronic HCV infection and infl ...... extra-hepatic manifestations.

@en

P1433

Q38157936-10C57214-F671-43DB-AF71-6C10B0FEEEBF

P1476

Q38157936-2D02B0FA-ACFE-44E9-8DA5-4D8964D8CD55

P2093

Q38157936-444FEDE2-E99D-4A2F-BAA2-8A4B4104D474

Q38157936-535706ED-714F-4EE7-BB2D-80300105F04D

Q38157936-54BA77E4-BB38-4FDB-83BA-1798715816FD

Q38157936-7F61D7C2-E23E-489E-922C-F73ECC5A5E02

Q38157936-8303DE8C-DBE6-4E9A-BD04-9B0846CC3242

Q38157936-C1DCDA41-39A0-4C65-94C6-4420E8B1ECEB

P2860

Q38157936-00D81973-4A50-477E-9F7C-43A06D6E5283

Q38157936-02168F92-0A67-49CD-AA6A-69FD0DD90892

Q38157936-068B35DE-AF88-408B-8943-F7635A326DAB

Q38157936-07220388-ED5F-4A87-9062-1111EEE790AD

Q38157936-098F2A10-DE43-4FFF-9CFC-E7B7563E660A

Q38157936-09A4F913-AAA1-4019-8E80-3C325E8F5A2F

Q38157936-0A5F7562-94F6-4A09-B9FB-263630C1A5A2

Q38157936-0FAC9EF1-7E07-4D49-8133-FEBDA2794B08

Q38157936-1099C96A-CA30-4F68-B9BB-F94FC206BEF8

Q38157936-1386CDE0-938F-45B0-A74D-06F4C2D7B38D

P304

Q38157936-48BB3991-7A24-48B7-8C2B-8EDE43FC7342

P31

Q38157936-51F6B948-86BD-481B-969B-C6B7433379F2

P356

Q38157936-44A2A398-CE89-4969-B0C7-767391B089F3

P433

Q38157936-8024E76F-A753-444A-A327-E32B5DD133FD

P478

Q38157936-4A7C3789-7649-4F5D-9200-5EE552E2572F

P50

Q38157936-905F78EB-07B7-4B0D-AD42-A274ADB69D29

Q38157936-9F42250D-6BE5-440F-91E3-433E390C7B38

P577

Q38157936-F4E32209-97ED-4585-89AD-73E26E23798B

P698

Q38157936-B0EEEEDE-48EF-448F-84C6-E2445A043493

P932

Q38157936-9C3010BE-11CE-4613-8C34-3CE1DBF26003

P356

P1433

World journal of hepatology

P1476

Chronic HCV infection and infl ...... extra-hepatic manifestations.

@en

P2093

Aldo Marrone

http://www.w3.org/2001/XMLSchema#string

Ausilia Sellitto

http://www.w3.org/2001/XMLSchema#string

Barbara Guerrera

http://www.w3.org/2001/XMLSchema#string

Luca Rinaldi

http://www.w3.org/2001/XMLSchema#string

Luciano Restivo

http://www.w3.org/2001/XMLSchema#string

Luigi E Adinolfi

http://www.w3.org/2001/XMLSchema#string

P2860

HCV-related nervous system disorders

The endocannabinoid system as an emerging target of pharmacotherapy

Evidence for association between hepatitis C virus seropositivity and coronary artery disease

Insights into the Pathobiology of Hepatitis C Virus-Associated Cirrhosis

Differential humoral immune response against hepatitis C virus antigenic synthetic peptides in infected patients with and without mixed cryoglobulinaemia

Association of Hepatitis C Virus Seropositivity With Inflammatory Markers and Heart Failure in Persons With Coronary Heart Disease: Data From the Heart and Soul Study

Role of the Receptor for the Globular Domain of C1q Protein in the Pathogenesis of Hepatitis C Virus-Related Cryoglobulin Vascular Damage

Pentoxifylline downregulates profibrogenic cytokines and procollagen I expression in rat secondary biliary fibrosis

Adaptive immune responses in acute and chronic hepatitis C virus infection

Unravelling hepatitis C virus replication from genome to function

P304

528-540

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4254/WJH.V5.I10.528

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24179612

http://www.w3.org/2001/XMLSchema#string

P932

3812455

http://www.w3.org/2001/XMLSchema#string